FULGENT GENETICS, INC. Operating Lease, Lease Income, Lease Payments
FULGENT GENETICS, INC. (FLGT) reported Operating Lease, Lease Income, Lease Payments of $17.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-03.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeaseLeaseIncomeLeasePayments · last filed 2024-05-03
- FULGENT GENETICS, INC. operating lease, lease income, lease payments for the quarter ending 2024-03-31 was $17.00K, a 62.22% decline year-over-year.
- FULGENT GENETICS, INC. operating lease, lease income, lease payments for the quarter ending 2023-12-31 was $35.00K, a 12.50% decline year-over-year.
- FULGENT GENETICS, INC. operating lease, lease income, lease payments for the quarter ending 2023-09-30 was $36.00K, a 25.00% decline year-over-year.
- FULGENT GENETICS, INC. operating lease, lease income, lease payments for the quarter ending 2023-06-30 was $38.00K, a 54.76% decline year-over-year.
- FULGENT GENETICS, INC. operating lease, lease income, lease payments for fiscal 2023 was $154.00K, a 42.75% decline from fiscal 2022.
- FULGENT GENETICS, INC. operating lease, lease income, lease payments for fiscal 2022 was $269.00K, a 34.87% decline from fiscal 2021.
- FULGENT GENETICS, INC. operating lease, lease income, lease payments for fiscal 2021 was $413.00K, a 186.81% increase from fiscal 2020.
- FULGENT GENETICS, INC. operating lease, lease income, lease payments for fiscal 2020 was $144.00K.
| Period end | Operating Lease, Lease Income, Lease Payments 3 month | Operating Lease, Lease Income, Lease Payments 6 month | Operating Lease, Lease Income, Lease Payments 9 month | Operating Lease, Lease Income, Lease Payments 12 month |
|---|---|---|---|---|
| 2024-03-31 | $17.00K 10-Q · filed 2024-05-03 | $52.00K derived: sum of 2 quarters · filed 2024-05-03 | $88.00K derived: sum of 3 quarters · filed 2024-05-03 | $126.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $71.00K derived: sum of 2 quarters · filed 2024-02-28 | $109.00K derived: sum of 3 quarters · filed 2024-02-28 | $154.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $36.00K 10-Q · filed 2023-11-03 | $74.00K derived: sum of 2 quarters · filed 2023-11-03 | $119.00K 10-Q · filed 2023-11-03 | $159.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-06-30 | $38.00K 10-Q · filed 2023-08-04 | $83.00K 10-Q · filed 2023-08-04 | $123.00K derived: sum of 3 quarters · filed 2024-05-03 | $171.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-03-31 | $45.00K 10-Q · filed 2024-05-03 | $85.00K derived: sum of 2 quarters · filed 2024-05-03 | $133.00K derived: sum of 3 quarters · filed 2024-05-03 | $217.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $88.00K derived: sum of 2 quarters · filed 2024-02-28 | $172.00K derived: sum of 3 quarters · filed 2024-02-28 | $269.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $48.00K 10-Q · filed 2023-11-03 | $132.00K derived: sum of 2 quarters · filed 2023-11-03 | $229.00K 10-Q · filed 2023-11-03 | $327.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $84.00K 10-Q · filed 2023-08-04 | $181.00K 10-Q · filed 2023-08-04 | $279.00K derived: sum of 3 quarters · filed 2024-02-28 | $357.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $97.00K 10-Q · filed 2023-05-05 | $195.00K derived: sum of 2 quarters · filed 2024-02-28 | $273.00K derived: sum of 3 quarters · filed 2024-02-28 | $354.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $176.00K derived: sum of 2 quarters · filed 2024-02-28 | $257.00K derived: sum of 3 quarters · filed 2024-02-28 | $413.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $78.00K 10-Q · filed 2022-11-07 | $159.00K derived: sum of 2 quarters · filed 2022-11-07 | $315.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $81.00K 10-Q · filed 2022-08-04 | $237.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $156.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $144.00K 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |